GENUS PLC (GENSY) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 14 55 sessions, October 16, 2025 to July 7, 2026
- Largest daily move
- -11.7% close of November 26, 2025
- 1-month change
- -6.9% closing prices, June 5, 2026 to July 7, 2026
Company Description
GENUS PLC (OTC: GENSY) is classified in the biotechnology industry within the Healthcare sector.
GENSY has declined 24.9% so far this year. The last closing price was $28.38.
This page collects what Stock Titan holds for GENSY, including price data, latest news, and short interest trends.
Stock Performance
GENUS PLC (GENSY) closed at $28.38 on July 7, 2026. So far this year, the price has lost 24.9%.
GENSY Metrics & Rankings
Price returns through July 7, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
GENUS PLC has 5 recent news articles. Key topics include acquisition, AI. View all GENSY news →
SEC Filings
Short Interest History
Short interest in GENUS PLC (GENSY) currently stands at 9 shares. Since October 2025, short interest has decreased by 91.6%.
Days to Cover History
Days to cover for GENUS PLC (GENSY) currently stands at 1.3 days, up 29% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has decreased by 38.6%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
GENSY Company Profile & Sector Positioning
GENUS PLC (GENSY) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing GENSY often look at related companies in the same sector, including NORTHWEST BIOTHRPUTCS INC (NWBO), CYTODYN INC (CYDY), CLINUVEL PHARMS LTD (CLVLY), NUO THERAPEUTICS INC NEW (AURX), and ALK-ABELLO AS (AKBLF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GENSY's relative position within its industry.